Five Ways Medical Society Board Membership Can Inform Selection of External Experts

Medical societies and associations play an important role in the healthcare ecosystem. They offer education, a platform for networking, they advocate for their members and develop medical guidelines. In this blog we discuss why experts, who serve on medical society boards and committees, make excellent external advisors for medical affairs groups and how to identify them.

Read more

Digital Influencers: The Emergence of a New Class of Experts

Over the last few years the dialogue about the role and importance of digital influencer has shifted from whether to listen and engage to how to best do it. In our recent webinar “Who are digital influencers and what is their importance to MSLs/medical affairs and an effective medical strategy?” a panel of experts discusses these important questions. This blog summarizes the main points; the webinar recording is available for everybody who wants to delve deeper into this important and current topic.

Read more

“New Normal” or “Different Abnormal”? A Discussion About the Future of Virtual Interaction with External Experts

An extended period of time working remotely due to COVID-19 has challenged medical affairs professionals, and especially field medical, to find new, virtual ways to engage with their external experts. In a recent webinar an expert panel discussed necessary changes, surprising developments and trends brought on by this unprecedented situation. This blog provides a summary of the most salient points. You can also listen to the recording for a more in-depth discussion of these important topics.

Read more

One Size Doesn’t Fit All: Finding Experts for Every Stage of the Drug Lifecycle

Lifecycle management is critical for the success of a drug and pharmaceutical companies seek the advice of a variety of external experts to inform all drug development phases from research to post-launch activities. In this week’s blog we discuss the roles external experts play throughout the drug lifecycle, define four broad categories of experts and map them to stages throughout drug discovery, development and commercialization.

Read more

COVID-19: Scleroderma

Scleroderma, or systematic sclerosis, is an autoimmune disorder caused by an overactive immune system that attacks the body's own tissues. The use of immunosuppressive treatment in scleroderma patients makes them more vulnerable to infection, including COVID-19. Also, lung involvement, i.e. lung fibrosis, is a common manifestation of scleroderma which increases the risk for patients who may be infected by the coronavirus. In this week's TTL, we review global experts and rising stars with research activities related to scleroderma and COVID-19.

Read more

5 Reasons Why Medical Affairs Need to Engage Digital Influencers

In a world increasingly dominated by digital and social media interactions digital influencers are fast becoming an important new group of external experts for medical affairs groups. In this week’s blog we discuss five reasons why medical affairs need to engage digital influencers.

Read more